2 Ml Doxorubicin Hydrochloride Liposome Injection

Name: 2 Ml Doxorubicin Hydrochloride Liposome Injection
Brand: NEETCO BIOPHARMA
Price: 3200 INR
Availability: InStock

Price 3200 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

2 Ml Doxorubicin Hydrochloride Liposome Injection Specification

Indication
Cancer (various types including breast cancer, ovarian cancer, multiple myeloma, Kaposis sarcoma)

Salt Composition
Doxorubicin Hydrochloride Liposome

Dosage Form
Injection

Feature
Pegylated liposomal formulation for prolonged circulation and reduced cardiotoxicity

Ingredients
Doxorubicin Hydrochloride in a Liposomal formulation

Application

Ph Level
Neutral (approx. pH 7.0)

Physical Color/Texture
Translucent red solution

Fermentation Smell
Odorless

Storage Instructions
Store at 2°C to 8°C. Do not freeze. Protect from light.

Shelf Life
24 months from manufacturing date

Prescription/Non-Prescription
Prescription

Contraindications
Hypersensitivity to doxorubicin, severe hepatic impairment, recent myocardial infarction, severe myelosuppression

Packaging Type
Glass vial

Strength
10 mg/2 mL

Route of Administration
Intravenous infusion

Brand Name
Doxolip (example name)

Regulatory Status
US FDA/EMA/WHO GMP approved manufacturing

Usage
Only under supervision of qualified oncologist

Precautions
Monitor cardiac function, complete blood counts, liver and renal function before and during therapy

About 2 Ml Doxorubicin Hydrochloride Liposome Injection

Experience the peerless and splendid efficacy of Doxolip-2 mL Doxorubicin Hydrochloride Liposome Injection (10 mg/2 mL), meticulously crafted for superior cancer treatment. Offered in a translucent red solution within a neutral pH glass vial, this terrific formulation features PEGylated liposomes for prolonged circulation and minimized cardiotoxicity. Available only with prescription and for intravenous infusion, it is US FDA/EMA/WHO GMP certified. Grab this promotion through leading distributors, exporters, suppliers, and traders in India. Try now-always under oncologist supervision!

Application and Specific Usage

Doxolip is used exclusively for intravenous application in medical facilities authorized to administer chemotherapy. Its site of action is systemic, targeting cancer cells in conditions such as breast cancer, ovarian cancer, multiple myeloma, and Kaposi's sarcoma. Each 2 mL vial is to be used under the vigilant supervision of a qualified oncologist, ensuring precise dosage and safety protocols for optimal patient benefit.

Supply Ability and Packing Details

Our supply process guarantees steady availability of Doxolip. Samples can be provided upon request, with packing and dispatch managed efficiently through our FOB ports across India. The asking price depends on order specifications and quantity, with each glass vial securely packed for transport and storage. We ensure regulatory compliance and timely dispatch, meeting international standards for medicinal exports.

FAQ's of 2 Ml Doxorubicin Hydrochloride Liposome Injection:

Q: How is Doxolip 2 mL Injection administered?

A: Doxolip is administered as an intravenous infusion by a qualified healthcare professional, typically in a hospital or oncology clinic setting.

Q: What types of cancers is Doxolip indicated for?

A: Doxolip is indicated for various cancers including breast cancer, ovarian cancer, multiple myeloma, and Kaposi's sarcoma, as part of a comprehensive chemotherapy regimen.

Q: When should cardiac and liver function be monitored during Doxolip therapy?

A: Cardiac and liver functions must be evaluated before starting treatment and periodically during therapy to prevent serious side effects.

Q: Where should Doxolip be stored to maintain its efficacy?

A: Doxolip must be stored at temperatures between 2C and 8C, protected from light, and should never be frozen.

Q: What benefits does the PEGylated liposomal formulation offer?

A: The PEGylated liposomal formulation prolongs the circulation of doxorubicin, reduces overall cardiotoxicity, and enhances targeted anticancer effects.

Q: Who should avoid using Doxolip?

A: Doxolip is contraindicated in patients with hypersensitivity to doxorubicin, severe hepatic impairment, recent myocardial infarction, or severe myelosuppression.

Tell us about your requirement